Bio-Techne (TECH) Tops Q4 EPS by 17c

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.87, $0.17 better than the analyst estimate of $1.70. Revenue for the quarter came in at $259 million versus the consensus estimate of $244.62 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'